Search Results

You searched for : Glaxo  

ENO celebrates Cricket banter in a witty new campaign featuring Aakash Gupta

From team clashes between fans to India’s love for food, the comedian brings the cricket season alive through various avatars...
Mar 17

Sensodyne Sets a GUINNESS WORLD RECORD™️ to kickstart 2025 World Oral Health Day campaign

World Oral Health Day campaign will educate people on importance of good oral health & ensure better understanding through free dental screening tool ...
Mar 05

Unveiling the Menace of Counterfeit Medicines: Telangana Seizes Fake Drugs Worth Rs 33.3 Lakhs

By working together to address this grave threat, we can uphold the integrity of the pharmaceutical industry and protect the health and safety of individuals ...
Mar 07

India’s first indigenously developed vaccine against cervical cancer will hit the market soon

India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ...
Sep 02

Cancer cure now possible? Major breakthrough Treatment with Dostarlimab

A cancer patient has new hope for a cancer cure now. Let us look into details to beat cancer with the new drug Dostarlimab. ...
Jun 09

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update...
Aug 02

GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with anaemia

GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (...
Jul 17

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ...
Jun 22

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG....
Jun 14

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

GSK's Covid product could be soon in the market after the emergency medical application review...
May 11

FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker

GSK gets FDA nod for Jemperli indicated for endometrial cancer...
Apr 26

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK

The agreement is for the advancement of multiple pre-phase 2 programs...
Mar 22

Sanofi's mRNA vaccine would not be available this year ; CEO

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO ...
Feb 15

GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers Symposium

GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ...
Jan 18

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19

Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ...
Jan 12

Sosei Heptares collaborates with GlaxoSmithKline targeting immune disorders of the digestive system

GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform...
Dec 22

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalized adults with COVID-19

ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19....
Dec 18

FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US

BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ...
Dec 18

Conflicts of interest among the UK government’s covid-19 advisers are not transparent

The BMJ’s attempts to discover more have been thwarted ...
Dec 11

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left....
Dec 11

25 Matching result(s) found!

-Advertisements-




Trending Now

Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025